NCT05070910
Completed
N/A
Determining the Efficacy of the Neurodevelopmental Treatment Contemporary Practice Model for the Treatment of Children With Cerebral Palsy or Other Neuromuscular Conditions to Improve Functional Outcomes.
MultiCare Health System Research Institute1 site in 1 country14 target enrollmentOctober 25, 2021
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cerebral Palsy
- Sponsor
- MultiCare Health System Research Institute
- Enrollment
- 14
- Locations
- 1
- Primary Endpoint
- Significant increase in functional outcomes in COPM scores
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this study is to determine whether there is a functional change in children with Cerebral Palsy (CP) and other neuromuscular disorders participating in Neurodevelopmental Treatment (NDT) intervention using the contemporary practice model (CPM).
Investigators
Eligibility Criteria
Inclusion Criteria
- •The children will be aged 2 to 15 years with a diagnosis of CP, hypotonia, global developmental delay and/ or neuromuscular disorders not otherwise specified.
- •Children must also be willing to receive physical guidance for movement and clearly attempt to respond to simple instructions on request.
- •Children and their families are available and willing to attend the practicum portion of the course for both blocks.
Exclusion Criteria
- •Parent/Guardian unable to complete the 4 required interview sessions.
- •Unable to commit to attending 75% of practicum sessions.
Outcomes
Primary Outcomes
Significant increase in functional outcomes in COPM scores
Time Frame: Significant change after an 8 week NDT-CPM treatment occurring from November 2, 2021 to completion on March 12, 2022
Change functional outcomes in COPM scores after NDT-CPM treatment.
Study Sites (1)
Loading locations...
Similar Trials
Completed
N/A
Brain Function in Children With Congenital Heart Disease (CHD)Congenital Heart DiseaseNCT02814539Bea Latal50
Recruiting
N/A
Investigation of the Relationship Between Development, Neurological Assessment and Object Permanence in High Risk Infants.Infant DevelopmentNCT05749796Tokat Gaziosmanpasa University32
Unknown
N/A
Examining Developmental Outcomes of Children Diagnosed With CLN2 DiseaseBatten DiseaseCLN2Neuronal Ceroid-LipofuscinosesNCT03862274Jessica Scherr30
Unknown
N/A
A Cross Sectional Evaluation of the Development in Children Age 4 to 7 Infected or Exposed to HIV From the ANRS 12140 Cohort (Pediacam)HIVHIV-uninfected ChildrenChildren Exposed to HIVNCT02570334ANRS, Emerging Infectious Diseases400
Completed
Phase 3
Individualized Neurodevelopmental TreatmentCerebral PalsyNCT00922077Hellenic Society for Disabled Children1